Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects With Decompensated Heart Failure (ASCEND-HF).

Trial Profile

Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects With Decompensated Heart Failure (ASCEND-HF).

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Nov 2016

At a glance

  • Drugs Nesiritide (Primary)
  • Indications Acute heart failure; Decompensated heart failure
  • Focus Registrational; Therapeutic Use
  • Acronyms ASCEND-HF
  • Sponsors Janssen-Cilag; Scios
  • Most Recent Events

    • 16 Nov 2016 Results (n=5741) comparing hospitalization for chronic heart failure patients with patients having more recent heart failure diagnosis (de novo), presented at the 89th Annual Scientific Sessions of the American Heart Association.
    • 27 Jan 2016 Results of post-hoc analysis published in the European Journal of Heart Failure
    • 28 Dec 2015 Results assessing liver function test published in the European Journal of Heart Failure (n = 4228).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top